Back to Sites

Sizwe CRS

Site Number

31929

Address

Sizwe Tropical Disease Hospital
2 Modderfontein Road
Sandringham
Johannesburg, Gauteng 2041
South Africa

IMPAACT Members at this Site

Linah Mutshinya CRS Coordinator

Pauline Howell CRS Leader

Ina de Jongh CTU Coordinator

Helen Rees CTU Principal Investigator

Ian Sanne CTU Principal Investigator

Tidimalo Tshukudu Study Coordinator

Studies at this Site

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV.

DAIDS Number

Research Area

Study Status

Participants Off Study and Primary Analysis Completed

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Follow Up

IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

Closed to Follow Up